Column Group IV, LP, 10% Owner at NGM BIOPHARMACEUTICALS INC (NGM), bought 65,238 shares at $12.90 ($842K) on 2022-05-16, disclosed to the SEC on 2022-05-17.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $12.90 | 1,094 | $14K | 1.7% |
| 2 | $12.90 | 32,072 | $414K | 49.2% |
| 3 | $12.90 | 32,072 | $414K | 49.2% |
| Total | $12.90 avg | 65,238 | $842K | 100% |
| Filing → |
| NGM | BUY | 2022-06-06 | $877K | — | Filing → |